News

Investors Unite: Class Action Against ZoomInfo Technologies

Investors Unite: Class Action Against ZoomInfo Technologies

Investors Mobilized for Class Action Against ZoomInfo

In recent news, a significant class action lawsuit has emerged against ZoomInfo Technologies, Inc. This lawsuit has caught the attention of many investors who experienced substantial losses during a specified class period. Robbins Geller Rudman & Dowd LLP, a prominent law firm, is spearheading this initiative, urging those affected to become lead plaintiffs.

The class action lawsuit, titled City of Pontiac Police and Fire Retirement System v. ZoomInfo Technologies, Inc., has raised serious allegations against ZoomInfo and its leadership. According to the allegations, during the class period, numerous misleading statements were made that ultimately misrepresented the company’s financial health and operational stability.

Understanding the Class Period

This class period began on November 10, 2020, and runs through August 5, 2024. Investors who purchased ZoomInfo Class A common stock during this timeframe may be eligible to participate in the lawsuits by applying for the lead plaintiff role by November 4, 2024. This is an opportunity for those investors to take a stand and potentially recover some of their losses.

The Allegations Against ZoomInfo

ZoomInfo specializes in software and data solutions, providing essential business information and customer contacts to its clients. However, the allegations state that during the class period, the company misled its investors regarding the sustainability of its customer base and revenue growth. The lawsuit accuses ZoomInfo of inflating financial results due to the temporary effects of heightened demand caused by the COVID-19 pandemic. This practice raises serious questions about the viability of ZoomInfo’s reported financial health.

Key Issues Raised in the Lawsuit

The lawsuit outlines several serious allegations against ZoomInfo, including: (i) the company utilized coercive auto-renew policies against customers, (ii) there was a significant decline in client retention rates, (iii) and many clients were either scaling back their usage or ceasing their business relationships with ZoomInfo altogether. Together, these issues purportedly led to an inaccurate portrayal of ZoomInfo's financial metrics and performance.

Recent Financial Disclosures

ZoomInfo's challenges became even more pronounced in November 2022, when the company disclosed it had experienced increased scrutiny from customers during renewal processes. As a result, they reported a decline in performance metrics, indicating a troubling pattern emerging for the company.

Following that, the company reported that total Remaining Performance Obligations (RPOs) dropped, signaling instability. This significant downturn led to a drastic stock price decline of over 29%. The downward trend continued, with later financial results showing further deterioration in their customer base and revenue guidance.

The Path Forward

As of now, ZoomInfo continues to adjust its operational strategies in response to these challenges. Recent earnings announcements revealed further reduction in expected revenues, with declines in high-value client contracts. This decline has contributed to another severe drop in stock prices. Investors are urged to act quickly and strategically to protect their financial interests.

Taking Action: How Investors Can Get Involved

For any investors impacted during the class period, now is the time to consider taking action. Robbins Geller encourages those who have faced substantial losses to gather relevant documentation and seek to be appointed as lead plaintiffs in this pivotal class action.

Contact Details for More Information

Any investor interested, or seeking further clarification, can contact the Robbins Geller legal team, including J.C. Sanchez or Jennifer N. Caringal, directly at 800-449-4900, or via email at info@rgrdlaw.com.

Frequently Asked Questions

1. What prompted the class action against ZoomInfo Technologies?

The class action was initiated due to alleged securities violations and misleading financial disclosures that impacted many investors.

2. How can I participate in the class action lawsuit?

Individuals who purchased ZoomInfo Class A common stock from November 10, 2020, to August 5, 2024, can seek to be lead plaintiffs by contacting Robbins Geller.

3. What happens if I am appointed as a lead plaintiff?

Being appointed as a lead plaintiff allows you to represent the class and play an integral role in the legal proceedings of the case.

4. Is there a deadline to join the lawsuit?

Yes, interested parties must apply for lead plaintiff status by November 4, 2024.

5. How can I get in touch with Robbins Geller for further assistance?

You can contact Robbins Geller by calling 800-449-4900 or emailing info@rgrdlaw.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 179

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 133

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 171

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 161

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 175

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
vVARDIS Debuts on NYSE: Transforming Dental Care

Updated Category News Views 92

A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 94

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 170

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 136

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading

Top 5 Most Recently Viewed Articles

Under Armour and UNLESS: A New Era in Sustainable Sportswear

Updated Category News Views 185

Under Armour and UNLESS Unveil Groundbreaking Sportswear Innovative Launch at Milan Design Week Under Armour, Inc. and UNLESS, Inc. are set to revolutionize the sportswear industry by introducing a remarkable regenerative sportswear collection during Milan Design Week. This innovative project is a significant milestone representing their first collaboration, focusing on...

Continue Reading
Primech Holdings Expands Reach in North America, Targets Growth

Updated Category News Views 111

Primech Holdings Expands Presence in North America Primech Holdings Limited (NASDAQ: PMEC) has marked a significant milestone by opening its United States office in Edwardsville, Illinois. This expansion into North America is driven by the increasing demand for advanced, AI-driven cleaning solutions among institutional clients. Strategic Location for Growth Illinois was...

Continue Reading
Quantum Computing Inc. Secures $500 Million Through Private Placement

Updated Category News Views 296

Quantum Computing Inc. Strengthens Financial Backbone Quantum Computing Inc. (NASDAQ: QUBT), a pioneering company in the realm of integrated photonics and quantum optics technologies, has made headlines with its significant financing move. Recently, QCi announced that it has successfully arranged a private placement of common stock, amassing $500 million. This capital...

Continue Reading
Glaukos Takes Major Step with Epioxa™ FDA Application

Updated Category News Views 80

Glaukos Takes Major Step with Epioxa™ FDA Application Glaukos Corporation (NYSE: GKOS), a distinguished ophthalmic pharmaceutical and medical technology enterprise, has made significant strides by filing a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Epioxa™, its state-of-the-art keratoconus therapy. This innovative treatment...

Continue Reading
Freshpet's Upcoming Q1 2025 Results and Company Growth Insights

Updated Category News Views 222

Freshpet to Share First Quarter Results for 2025 Freshpet, Inc. is set to disclose its financial results for the first quarter concluding on March 31, 2025. The announcement is scheduled for the morning of May 5, 2025, just before the market opens. As a public company operating under Nasdaq: FRPT, Freshpet has garnered significant attention in the pet food industry....

Continue Reading